Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis

Sodium Zirconium Cyclosilicate for Renin–Angiotensin–Aldosterone System Inhibitor Optimization in Patients with Heart Failure with Reduced Ejection Fraction: A Retrospective Analysis

Abstract Introduction In this retrospective analysis, we evaluate the effectiveness of the potassium (K+) binder sodium zirconium cyclosilicate (SZC) in maintaining normokalemia and facilitating the initiation, optimization, and maintenance of renin–angiotensin–aldosterone system inhibitors (RAASi)...

Full description

Bibliographic Details
Main Authors: Rhys Williams, William Ford, Alexander James, Kerys Thomas, Aaron Wong
Format: Article
Language:English
Published: Adis, Springer Healthcare 2024-11-01
Series:Cardiology and Therapy
Subjects:
Heart failure
Hyperkalemia
Renin–angiotensin–aldosterone system inhibitor
Sodium zirconium cyclosilicate
Online Access:https://doi.org/10.1007/s40119-024-00388-z

Internet

https://doi.org/10.1007/s40119-024-00388-z

Similar Items